WCN26-2170 HIGH-DENSITY LIPOPROTEIN FUNCTIONALITIES IN PATIENTS WITH NEPHROTIC SYNDROME

Read full text Summarise with VIRAT
Authors: Hiroyuki Suzuki, Masatsune Ogura, Eri Muso
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We have reported that cholesterol efflux capacity (CEC) and anti-oxidative activity of high-density lipoprotein in non-nephrotic patients with chronic kidney disease (J Atheroscler Thromb. 2025. https://doi.org/10.5551/jat.65662.). There is little information on abnormalities of high-density lipoprotein (HDL) function in patients with nephrotic syndrome (NS). This study is aimed to explore the alteration of cholesterol efflux capacity and anti-oxidative activity of HDL in patients with nephrotic syndrome.

Fields of Study & Subjects

Cholesterol and Lipid Metabolism Lipoproteins and Cardiovascular Health Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105584–105584
Publication date
25 March 2026
Language
EN